Clinical Trial Update: Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tofacitinib for moderate to severe alopecia areata (totalis/universalis) completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Columbia University | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07